Allogeneic CAR-T cells with of HLA-A/B and TRAC disruption exhibit promising antitumor capacity against B cell malignancies. - Chen, Xinfeng; Tan, Binghe; Xing, Haizhou; Zhao, Xuan; Ping, Yu; Zhang, Zhen; Huang, Jianmin; Shi, Xiujuan; Zhang, Na; Lin, Boxu; Cao, Weijie; Li, Xin; et al. (Cancer Immunology, Immunotherapy, 2024)